• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    4.09 Down 0.08(1.92%) Apr 17, 4:00PM EDT
    |After Hours : 4.09 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 8,250   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit 8,250   -   -   -  
    Operating Expenses
    Research Development14,613  16,151  20,063  16,869  
    Selling General and Administrative16,005  4,889  5,393  5,516  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (22,368) (21,040) (25,456) (22,385)
    Income from Continuing Operations
    Total Other Income/Expenses Net96  98  65  82  
    Earnings Before Interest And Taxes(22,272)(20,942)(25,391)(22,303)
    Interest Expense -   -   -   -  
    Income Before Tax(22,272)(20,942)(25,391)(22,303)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(22,272)(20,942)(25,391)(22,303)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (22,272) (20,942) (25,391) (22,303)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (22,272) (20,942) (25,391) (22,303)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.